SiteOne Therapeutics

company

About

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics.

  • 1 - 10

Details

Last Funding Type
Series A
Last Funding Money Raised
$1.50M
Industries
Biotechnology,Health Diagnostics,Medical,Therapeutics
Founded date
Jan 1, 2010
Number Of Employee
1 - 10
Operating Status
Active

SiteOne Therapeutics is a San Francisco-based company that develops novel therapeutics and diagnostics. They develop products safely, effectively, and efficiently treat acute and chronic pain without the limitations of existing therapies, such as NSAIDs and opioids. Their lead therapeutic candidates are highly selective inhibitors of a voltage-gated sodium ion channel, Naᵥ1.7, which plays a critical role in the generation and conduction of pain signals.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$17.77M
SiteOne Therapeutics has raised a total of $17.77M in funding over 2 rounds. Their latest funding was raised on Jan 6, 2017 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 6, 2017 Series B $15M 1 Detail
Jul 15, 2015 Series Unknown $1.27M 1 Detail
Sep 24, 2014 Series A $1.50M 1 Sears Capital Management Detail

Investors

Number of Lead Investors
Number of Investors
1
1
SiteOne Therapeutics is funded by 1 investors. Sears Capital Management are the most recent investors.
Investor Name Lead Investor Funding Round
Sears Capital Management Series B